# Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery

> **NCT07478211** · — · RECRUITING · sponsor: **Lia Bally** · enrollment: 40 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1
- Energy Metabolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07478211
- **Lead sponsor:** Lia Bally
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-09
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- Gertrud and Walter Siegenthaler Foundation
- Burgergemeinde
- Bangerter Foundation and Swiss Academy of Medical Science
- mylife Diabetes Care AG
- Innosuisse - Swiss Innovation Agency
- CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
- University of Bern
- Insel Gruppe AG, University Hospital Bern

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478211, "Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT07478211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*